Zerion Pharma
PrivateLast Round
VC Round
Jun 30, 2026
Total Funding Raised
$8.51M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Zerion Pharma is a pharmaceutical development company that provides a proprietary formulation platform, Dispersome®, to improve the solubility and bioavailability of poorly soluble small-molecule drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zerion Pharma Comparables
Compare Zerion Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| inflamed pharma | 86% | |
| DelAQUA Pharmaceuticals, Inc. | 83% | |
| Intract Pharma | 83% | |
Zerion Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 30, 2026 | ||||
| Grant | Jan 12, 2026 | ||||
| Early Funding | May 4, 2023 | ||||
| Early Funding | Dec 14, 2021 | ||||
| Grant | Oct 1, 2020 | ||||
Seed | Jun 1, 2020 |
Key People
Founding team and executive leadership
Zerion Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ligand Pharmaceuticals | VC Round |
| Innovation Fund Denmark | Grant |
| Eurostars SME programme | Grant |
| The Export and Investment Fund of Denmark | Early Funding, Seed, Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 173% MoM, reaching 2.8K.
- Jan 12, 2026
Developing first HER2 oral monoclonal antibody for breast cancer treatment.
Zerion Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Zerion Pharma's valuation, stock price, and market status.